These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
117 related articles for article (PubMed ID: 21439375)
1. Improvement of oxaprozin solubility and permeability by the combined use of cyclodextrin, chitosan, and bile components. Maestrelli F; Cirri M; Mennini N; Zerrouk N; Mura P Eur J Pharm Biopharm; 2011 Aug; 78(3):385-93. PubMed ID: 21439375 [TBL] [Abstract][Full Text] [Related]
2. Influence of cyclodextrins and chitosan, separately or in combination, on glyburide solubility and permeability. Zerrouk N; Corti G; Ancillotti S; Maestrelli F; Cirri M; Mura P Eur J Pharm Biopharm; 2006 Apr; 62(3):241-6. PubMed ID: 16226882 [TBL] [Abstract][Full Text] [Related]
3. Development and characterization of fast dissolving tablets of oxaprozin based on hybrid systems of the drug with cyclodextrins and nanoclays. Maestrelli F; Mura P; Cirri M; Mennini N; Ghelardini C; Di Cesare Mannelli L Int J Pharm; 2017 Oct; 531(2):640-649. PubMed ID: 28522425 [TBL] [Abstract][Full Text] [Related]
4. Formulation of rifampicin-cyclodextrin complexes for lung nebulization. Tewes F; Brillault J; Couet W; Olivier JC J Control Release; 2008 Jul; 129(2):93-9. PubMed ID: 18514353 [TBL] [Abstract][Full Text] [Related]
5. Novel lipid-based formulations enhancing the in vitro dissolution and permeability characteristics of a poorly water-soluble model drug, piroxicam. Prabhu S; Ortega M; Ma C Int J Pharm; 2005 Sep; 301(1-2):209-16. PubMed ID: 16046087 [TBL] [Abstract][Full Text] [Related]
6. Mathematical modelling of the transport of hydroxypropyl-β-cyclodextrin inclusion complexes of ranitidine hydrochloride and furosemide loaded chitosan nanoparticles across a Caco-2 cell monolayer. Sadighi A; Ostad SN; Rezayat SM; Foroutan M; Faramarzi MA; Dorkoosh FA Int J Pharm; 2012 Jan; 422(1-2):479-88. PubMed ID: 22101294 [TBL] [Abstract][Full Text] [Related]
7. Analysis of physicochemical properties of ternary systems of oxaprozin with randomly methylated-ß-cyclodextrin and l-arginine aimed to improve the drug solubility. Mennini N; Maestrelli F; Cirri M; Mura P J Pharm Biomed Anal; 2016 Sep; 129():350-358. PubMed ID: 27454086 [TBL] [Abstract][Full Text] [Related]
8. Hybrid systems based on "drug - in cyclodextrin - in nanoclays" for improving oxaprozin dissolution properties. Mura P; Maestrelli F; Aguzzi C; Viseras C Int J Pharm; 2016 Jul; 509(1-2):8-15. PubMed ID: 27188644 [TBL] [Abstract][Full Text] [Related]
9. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: Effect of cyclodextrin complexation. Mennini N; Cirri M; Maestrelli F; Mura P Int J Pharm; 2016 Dec; 515(1-2):684-691. PubMed ID: 27825863 [TBL] [Abstract][Full Text] [Related]
10. Inorganic-polymer nanohybrid carrier for delivery of a poorly-soluble drug, ursodeoxycholic acid. Choi G; Lee JH; Oh YJ; Choy YB; Park MC; Chang HC; Choy JH Int J Pharm; 2010 Dec; 402(1-2):117-22. PubMed ID: 20933070 [TBL] [Abstract][Full Text] [Related]
11. Chitosan-graft-β-cyclodextrin nanoparticles as a carrier for controlled drug release. Yuan Z; Ye Y; Gao F; Yuan H; Lan M; Lou K; Wang W Int J Pharm; 2013 Mar; 446(1-2):191-8. PubMed ID: 23422276 [TBL] [Abstract][Full Text] [Related]
12. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation. Badr-Eldin SM; Elkheshen SA; Ghorab MM Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829 [TBL] [Abstract][Full Text] [Related]
13. Dissolution and permeation properties of naproxen from solid-state systems with chitosan. Corti G; Maestrelli F; Cirri M; Mura P; Zerrouk N Drug Deliv; 2008 Jun; 15(5):303-12. PubMed ID: 18763161 [TBL] [Abstract][Full Text] [Related]
14. Influence of cyclodextrin complexation on piroxicam gel formulations. Jug M; Bećirević-Laćan M; Kwokal A; Cetina-Cizmek B Acta Pharm; 2005 Sep; 55(3):223-36. PubMed ID: 16375834 [TBL] [Abstract][Full Text] [Related]
15. Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells. Maestrelli F; Zerrouk N; Chemtob C; Mura P Int J Pharm; 2004 Mar; 271(1-2):257-67. PubMed ID: 15129993 [TBL] [Abstract][Full Text] [Related]
16. Erlotinib complexation with randomly methylated Erdoğar N; Akkın S; Varan G; Bilensoy E Pharm Dev Technol; 2021 Sep; 26(7):797-806. PubMed ID: 34219578 [TBL] [Abstract][Full Text] [Related]
17. Glucosamine HCl as a new carrier for improved dissolution behaviour: effect of grinding. Al-Hamidi H; Edwards AA; Mohammad MA; Nokhodchi A Colloids Surf B Biointerfaces; 2010 Nov; 81(1):96-109. PubMed ID: 20674291 [TBL] [Abstract][Full Text] [Related]
18. In vitro and in vivo studies on the complexes of glipizide with water-soluble β-cyclodextrin-epichlorohydrin polymers. Nie S; Zhang S; Pan W; Liu Y Drug Dev Ind Pharm; 2011 May; 37(5):606-12. PubMed ID: 21469949 [TBL] [Abstract][Full Text] [Related]
19. In vitro cytotoxicity of paclitaxel/beta-cyclodextrin complexes for HIPEC. Bouquet W; Boterberg T; Ceelen W; Pattyn P; Peeters M; Bracke M; Remon JP; Vervaet C Int J Pharm; 2009 Feb; 367(1-2):148-54. PubMed ID: 18938234 [TBL] [Abstract][Full Text] [Related]
20. Randomly methylated β-cyclodextrin derivatives enhance taxol permeability through human intestinal epithelial Caco-2 cell monolayer. Fenyvesi F; Kiss T; Fenyvesi E; Szente L; Veszelka S; Deli MA; Váradi J; Fehér P; Ujhelyi Z; Tósaki A; Vecsernyés M; Bácskay I J Pharm Sci; 2011 Nov; 100(11):4734-44. PubMed ID: 21660974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]